A pilot study of Cancer Genome Profiling in the African American Population
MetadataShow full item record
AbstractAs an African American woman, it is imperative that I change the perception that we have on healthcare and the pharmaceuticalindustry. It is a common but respectable misconception that Medicine and research does not work in the African American population. Many of these misconceptions have developed over time from the medical mistreatment in diverse population, specifically African Americans. (T.S.E, Henriette Lacks etc.) Studies show that Breast and Ovarian cancer are two of the most prevalent cancers among women worldwide. African American woman have a lower incidence in both Breast and Ovarian cancers buthave a higher mortality rate compared to their white counterparts. Genetics, Access to care, treatment options, and other healthcare disparities play a vitalrole in overall survival rates among this diverse population. While there has been research on both cancer types, there is limited data and research specially for AfricanAmerican women.
DescriptionMaster of Science in Pharmaceutical Sciences Departmental Seminar, December 8, 2023
Rights/TermsAttribution-NonCommercial-NoDerivatives 4.0 International
KeywordTuskegee Syphilis Study.
Lacks, Henrietta, 1920-1951
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/21227
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International